Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programs

May 29, 2026 06:50 AM EDTUpdated 07:19 AM DealsR&D Pfiz­er strikes In­novent deal worth up to $10.5B for a dozen can­cer pro­grams Ayisha Sharma News Reporter On the eve of this year’s AS­CO an­nu­al meet­ing, Pfiz­er said it is team­ing up with Chi­na’s In­novent Bi­o­log­ics to ad­vance a port­fo­lio of 12 … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER